The safety of sulfonylurea therapy in type 2 diabetes: have we reached the practical limits of our evidence base?
Crossref DOI link: https://doi.org/10.1007/s00125-014-3417-3
Published Online: 2014-10-17
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Johnson, Jeffrey A.
Text and Data Mining valid from 2014-10-17